NAMS Price Prediction Next Week
Analysis and Insights
News and Fundamental Analysis:
NewAmsterdam Pharma (NAMS) has recently filed for a $500 million mixed securities shelf, indicating potential future capital-raising activities. The company has also initiated a $300 million offering of ordinary shares and reported positive data on its cholesterol treatment, Obicetrapib, which could serve as a catalyst for growth.
Technical Analysis:
The stock is currently trading at $22.88 with a neutral RSI of 58.75, indicating no overbought or oversold conditions. The MACD is slightly bullish at 0.47, suggesting upward momentum. Key support levels are at $19.05 (Fibonacci S1) and $17.59 (Fibonacci S2), while resistance is at $23.79 (Fibonacci R1) and $25.25 (Fibonacci R2).
Price Prediction:
Based on the analysis, the stock is expected to trade between $18 and $25 next week. Considering the bullish momentum and positive news, the price is likely to reach $25.
Recommendation:
Buy NAMS as the stock is expected to rise to $25 next week, driven by positive developments and bullish technical indicators.
NAMS Similar Chart Price Prediction
The price of NAMS is predicted to go up -2.61%, based on the high correlation periods with DYN. The similarity of these two price pattern on the periods is 94.98%.
NAMS
DYN
Down: -2.61%Similarity: 94.98%
NAMS Revenue Forecast
NAMS EPS Forecast
NAMS FAQs
What is NAMS revenue forecast for next quarter？
NAMS Analyst's Forecast
Yasmeen Rahimi
Piper Sandler
Buy
2024-09-23
Price Target
$37
Upside
+139.17%
